Here you can download different charts about cases by world region, prevalence rates, and progress towards polio eradication and much more.
Polio is an infectious disease that is caused and transmitted by the poliovirus. Most infections do not lead to any symptoms, but—among the unvaccinated—...between 1 in 50 and 1 in 500 infections result in paralysis. For some it leads to death.
At the start of the 20th century, polio was endemic worldwide, with large epidemic outbreaks every year. But with the development of two vaccines in the 1950s, countries began eliminating polio one by one.
more
A comprehensive briefing by Half of Syria
April 2020
A comprehensive briefing on the critical challenges of the COVID-19 pandemic to Syrians, as reported by Syrian civil society organisations. These challenges have been collated following extensive interviews with the teams of member and partner... organisations working in the field in various sectors: health, child care, education, women’s empowerment, media and culture, research, human rights and accountability, relief and social services, and local governance.
This comprehensive briefing also include concrete recommendations formulated by the Syrian civil society.
more
The guidance provides critical considerations and practical checklists to keep schools safe. It also advises national and local authorities on how to adapt and implement emergency plans for educational facilities.
In the event of school closures, the guidance includes recommendations to mitigate... against the possible negative impacts on children’s learning and wellbeing. This means having solid plans in place to ensure the continuity of learning, including remote learning options such as online education strategies and radio broadcasts of academic content, and access to essential services for all children. These plans should also include necessary steps for the eventual safe reopening of schools.
Where schools remain open, and to make sure that children and their families remain protected and informed.
more
MEDBOX Issue Brief no.9 ,1 Febr. 2021
As the nation’s public health leader, the Centers for Disease Control and Prevention (CDC) is actively engaged in a national effort to protect the public’s health from the harmful effects of climate change. Scientists from CDC’s National Center for Emerging and Zoonotic Infectious Diseases (NC...EZID) are at the forefront of many of these efforts. This report highlights some of that work and also looks ahead to the important work yet to come.
more
This report provides an overview of the key information gaps and limitations in interpreting existing COVID-19 data
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future... supply security. In 2021, the AU set a target to produce and supply more than 60% of the vaccine doses on the continent by 2040.
In the last 18 months alone, more than 30 new African manufacturing projects have been announced and estimates indicate that the African vaccine market across all existing and projected novel products could range between US$ 2.8 billion and US$ 5.6 billion by 2040*, demonstrating the potential for a thriving regional industry to emerge.
more
Practice Paper in Brief 19
This paper brings together lessons from interviews with humanitarians and local responders, as well as existing literature, about the use of quarantine in urban environments during the humanitarian response to the Ebola Crisis
Objetivos
• Los dispositivos médicos enumerados en este documento proporcionan estándares mínimos y descripciones técnicas y especificaciones de dispositivos médicos para el tratamiento de soporte de COVID-19.§ • Estos dispositivos médicos no son limitados y son adaptables a todos los p...aíses de la región, independientemente de sus diferentes sistemas de atención médica y disparidades socioeconómicas. Además, se recomiendan para: o Terapia de soporte temprana y monitoreo de infecciones respiratorias agudas graves (IRAG) cuando se sospecha de infección por COVID-19; o Tratamiento de la insuficiencia respiratoria hipoxémica y el síndrome de dificultad respiratoria aguda (SDRA) en pacientes con COVID-19; o Manejo del shock séptico en pacientes con COVID-19.
more